Literature DB >> 25728127

A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle-specific genes.

Magdalena Harakalova1, Gijs Kummeling, Arjan Sammani, Marijke Linschoten, Annette F Baas, Jasper van der Smagt, Pieter A Doevendans, J Peter van Tintelen, Dennis Dooijes, Michal Mokry, Folkert W Asselbergs.   

Abstract

AIMS: Despite considerable progress being made in genetic diagnostics for dilated cardiomyopathy (DCM) using panels of the most prevalent genes, the cause remains unsolved in a substantial percentage of patients. We hypothesize that several previously described DCM genes with low or unknown prevalence have been neglected, which, if catalogued, could increase the yield of diagnostic DCM testing. The aim of this study is to catalogue all genetic evidence on DCM comprehensively. METHODS AND
RESULTS: We have conducted a systematic literature search on PubMed, Embase, and OMIM to find genes implicated in syndromic and non-syndromic DCM and peripartum cardiomyopathy (PPCM). Our search yielded 110 nuclear protein-coding genes and 24 mitochondrial DNA genes. For nuclear genes, in addition to 42 genes sufficiently reviewed previously (group A), we provide a comprehensive annotation of the level of genetic evidence for the remaining 68 genes (group B). Next, we investigated the tissue specificity of the collected genes using public RNA sequencing data. We show that genes primarily expressed in heart and skeletal muscle are more likely to result in DCM with possible skeletal myopathies, while genes expressed ubiquitously cause DCM with extramuscular manifestations.
CONCLUSION: This comprehensive analysis of DCM-associated genes revealed a much higher number of genes than currently screened in diagnostics. Since most genes in group B have only been found mutated in single DCM patients or families, their importance for DCM genetic diagnostics needs to be validated in large cohorts. Targeted sequencing of validated DCM-implicated protein-coding genes and mitochondrial DNA, together with consideration of the tissue specificity of mutated genes, may facilitate further genotype-phenotype studies in DCM.
© 2015 The Authors. European Journal of Heart Failure © 2015 European Society of Cardiology.

Entities:  

Keywords:  Dilated cardiomyopathy; Extramuscular manifestations; Genetic testing; Tissue expressivity

Mesh:

Substances:

Year:  2015        PMID: 25728127     DOI: 10.1002/ejhf.255

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  20 in total

1.  Analysis of selected genes associated with cardiomyopathy by next-generation sequencing.

Authors:  Viktoria Szabadosova; Iveta Boronova; Peter Ferenc; Iveta Tothova; Jarmila Bernasovska; Michaela Zigova; Jan Kmec; Ivan Bernasovsky
Journal:  J Clin Lab Anal       Date:  2017-06-08       Impact factor: 2.352

Review 2.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 3.  Genetics of dilated cardiomyopathy: practical implications for heart failure management.

Authors:  Andrew N Rosenbaum; Katherine E Agre; Naveen L Pereira
Journal:  Nat Rev Cardiol       Date:  2019-10-11       Impact factor: 32.419

Review 4.  A bibliometric review of peripartum cardiomyopathy compared to other cardiomyopathies using artificial intelligence and machine learning.

Authors:  M Grosser; H Lin; M Wu; Y Zhang; S Tipper; D Venter; J Lu; C G Dos Remedios
Journal:  Biophys Rev       Date:  2022-02-09

Review 5.  Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.

Authors:  Elham Kayvanpour; Farbod Sedaghat-Hamedani; Ali Amr; Alan Lai; Jan Haas; Daniel B Holzer; Karen S Frese; Andreas Keller; Katrin Jensen; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2016-08-30       Impact factor: 5.460

6.  Diagnosis, prevalence, and screening of familial dilated cardiomyopathy.

Authors:  Mary Sweet; Matthew R G Taylor; Luisa Mestroni
Journal:  Expert Opin Orphan Drugs       Date:  2015-06-22       Impact factor: 0.694

Review 7.  Determined to Fail--the Role of Genetic Mechanisms in Heart Failure.

Authors:  Elham Kayvanpour; Hugo A Katus; Benjamin Meder
Journal:  Curr Heart Fail Rep       Date:  2015-10

8.  Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy.

Authors:  Nina Nouhravesh; Gustav Ahlberg; Jonas Ghouse; Charlotte Andreasen; Jesper H Svendsen; Stig Haunsø; Henning Bundgaard; Peter E Weeke; Morten S Olesen
Journal:  Mol Genet Genomic Med       Date:  2016-09-17       Impact factor: 2.183

9.  Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23.

Authors:  Sophie Garnier; Magdalena Harakalova; Stefan Weiss; Michal Mokry; Vera Regitz-Zagrosek; Christian Hengstenberg; Thomas P Cappola; Richard Isnard; Eloisa Arbustini; Stuart A Cook; Jessica van Setten; Jorg J A Calis; Hakon Hakonarson; Michael P Morley; Klaus Stark; Sanjay K Prasad; Jin Li; Declan P O'Regan; Maurizia Grasso; Martina Müller-Nurasyid; Thomas Meitinger; Jean-Philippe Empana; Konstantin Strauch; Melanie Waldenberger; Kenneth B Marguiles; Christine E Seidman; Georgios Kararigas; Benjamin Meder; Jan Haas; Pierre Boutouyrie; Patrick Lacolley; Xavier Jouven; Jeanette Erdmann; Stefan Blankenberg; Thomas Wichter; Volker Ruppert; Luigi Tavazzi; Olivier Dubourg; Gérard Roizes; Richard Dorent; Pascal de Groote; Laurent Fauchier; Jean-Noël Trochu; Jean-François Aupetit; Zofia T Bilinska; Marine Germain; Uwe Völker; Daiane Hemerich; Ibticem Raji; Delphine Bacq-Daian; Carole Proust; Paloma Remior; Manuel Gomez-Bueno; Kristin Lehnert; Renee Maas; Robert Olaso; Ganapathi Varma Saripella; Stephan B Felix; Steven McGinn; Laëtitia Duboscq-Bidot; Alain van Mil; Céline Besse; Vincent Fontaine; Hélène Blanché; Flavie Ader; Brendan Keating; Angélique Curjol; Anne Boland; Michel Komajda; François Cambien; Jean-François Deleuze; Marcus Dörr; Folkert W Asselbergs; Eric Villard; David-Alexandre Trégouët; Philippe Charron
Journal:  Eur Heart J       Date:  2021-05-21       Impact factor: 29.983

10.  A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects.

Authors:  I H M van der Linde; Y L Hiemstra; R Bökenkamp; A M van Mil; M H Breuning; C Ruivenkamp; S W Ten Broeke; R F Veldkamp; J I van Waning; M A van Slegtenhorst; K Y van Spaendonck-Zwarts; R H Lekanne Deprez; J C Herkert; L Boven; P A van der Zwaag; J D H Jongbloed; M Bootsma; D Q C M Barge-Schaapveld
Journal:  Neth Heart J       Date:  2017-09-01       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.